Tag: prostatectomy

If you were suddenly kidnapped and blindfolded, then abandoned in a foreign land, you would want the best possible map to get safely to the border where you could figure out a homeward-bound plan. For men who are diagnosed with high-risk prostate cancer (PCa), it’s as if a hostile unknown enemy has abducted them, deprived keep reading

No one can dispute the superiority of multiparametric MRI (mpMRI) over transrectal ultrasound (TRUS) for detecting and characterizing prostate cancer (PCa) before biopsy and treatment. The past five years alone have seen a rapid accumulation of research evidence that mpMRI makes it possible to save medical dollars by avoiding unnecessary biopsies and their risks. While keep reading

A glance back in history reveals that not so many years ago, a prostatectomy to remove prostate cancer was a long and bloody surgery. It meant days in the hospital, a month of recovery, and higher rates of incontinence and ED than today’s robot-assisted laparascopic techniques. In comparison, today’s minimalist focal treatments for appropriate patients keep reading

Not long ago, I posted a blog on the ability of androgen deprivation therapy (ADT) to boost the effectiveness of radiation therapy for prostate cancer. This synergistic effect is very important for men with intermediate or higher risk cancer who can’t have (or don’t want) radical prostatectomy, since the greater the risk, the more likely keep reading

Question: What goes up and hasn’t come down? Answer: The use of Active Surveillance in the U.S. A February, 2019 study[i] examined U.S. management trends for low-risk prostate cancer since 2010. Prior to that, the standard of care for low-to-intermediate risk PCa was an “elephant gun” approach aimed at eradicating PCa by obliterating the gland. keep reading

What goes up may not come down.  At least, that’s what a new trend in prostate radiation therapy might lead you to believe. The trend is radiation dose escalation. It is occurring in patients who have a radical prostatectomy but whose clinical factors are considered to be a high risk for recurrence. By clinical factors, keep reading

For decades, thousands of men with insignificant PCa have been overtreated with prostatectomies. A new study raises questions about the practice and sheds light on the prostatectomy's decline. keep reading